Thoratec Corp. THOR (U.S.: Nasdaq)

  • AT CLOSE 4:00 PM ET 08/29/14
  • $25.00 USD
  • 0.26 1.05%
  • Volume 706,634
  • AFTER HOURS 4:45 PM ET 08/29/14
  • $25.003 0.003 0.01%
  • AFTER HOURS Vol 11,894
  • Volume 706,634
  • 65 Day Avg Vol 834,116
  • 1 Day Range 24.6711 - 25.2501
  • 52 Week Range 22.50 - 43.58 (08/07/14 - 10/31/13)
Compare
  • Compare to Benchmark:
  • DJIA
  • S&P 500
  • GLOBAL DOW
  • NASDAQ
  • Health Care
  • Compare to
  • Today's Open 24.83
  • Prior Day Close 24.74 (08/28/14)
  • Performance Today
  • THOR 1.05%
  • DJIA 0.11%
  • S&P Mid Cap 400 0.56%
  • Health Care 0.45%

Latest News Thoratec Corp.(THOR)

load more
Key Stock Data
?
P/E Ratio (TTM)
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Earnings Per Share (TTM)
A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
Market Capitalization
Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
Shares Outstanding
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Public Float
The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
Dividend Yield
A company's dividend expressed as a percentage of its current stock price.

Key Stock Data

  • P/E Ratio (TTM)
    21.01 (08/29/2014)
  • EPS (TTM)
    $1.19
  • Market Cap
    $1.41 B
  • Shares Outstanding
    56.89 M
  • Public Float
    56.36 M
  • Yield
    THOR has not issued dividends in more than 1 year.
  • Latest Dividend
    N/A
  • Ex-Dividend Date
    N/A
?
Shares Sold Short
The total number of shares of a security that have been sold short and not yet repurchased.
Change from Last
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
Percent of Float
Total short positions relative to the number of shares available to trade.

Short Interest

  • Shares Sold Short
    3.83 M (08/15/2014)
  • Change from Last
    -9.84%
  • Percent of Float
    6.80%
?
Money Flow Uptick/Downtick Ratio
Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

Stock Money Flow

  • Uptick/Downtick Trade Ratio
    0 2
    0.78
    Net Money Flow ($)
    -774,962

    Money flow gives a snapshot of relative buying and selling pressure in a stock. A ratio above one suggests greater buying pressure, below one suggests greater selling.

Advertisement

Competitors (THOR)

Company Change P/E (TTM)
GB

Greatbatch Inc.

 +0.66% 23.13
ABMD

Abiomed Inc.

 -0.08% 137.11
EW

Edwards Lifesciences Corp.

 +1.02% 13.92
BCR

C.R. Bard Inc.

 +0.57% 14.96
STJ

St. Jude Medical Inc.

 +1.11% 20.76
MDT

Medtronic Inc.

 +1.16% 21.35

Profile (THOR)

Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II...

6035 Stoneridge Drive
Pleasanton California 94588
United States

  • Employees 1,030
    Sector Medical Equipment
  • Sales or Revenue 502.82 M
    Industry Health Care
  • 1Y Sales Change 2.27%
    Fiscal Year Ends December 31 Download Reports

Research & Ratings Thoratec Corp.(THOR)

Per-Share Earnings, Actuals and Estimates

THOR will report Q3 earnings on 10/21/2014
Actual Analyst Range Consensus
0.60 0.40 0.20 0.00
Actual 0.49
0.39
Actual 0.38
0.41
Actual 0.41
0.39
Actual 0.43
0.43
0.25
0.26
Q32013 Q4 Q12014 Q2 Q3 Q4
Q4 2014 Estimate Trends
Current: $0.26
1 month ago: $0.48
3 months ago: $0.49

Financials Thoratec Corp.(THOR)

Net Income

0 6M 12M 18M 24M
Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014
Jun 2014 5-quarter trend
Net Income Growth -24.91%
Sales or Revenue 118.06 M
Sales or Revenue Growth -9.52%
EBITDA +29.58 M
2013 5-year trend
Net Income Growth +30.59%
Sales or Revenue 502.82 M
Sales or Revenue Growth +2.27%
EBITDA +126.21 M
Advertisement
  • Back to Top«
    •

  • Customer Service

  • Customer Center
  • Contact Us
  • WSJ Weekend
  • Contact Directory
  • Corrections
    •

  • Policy

  • Privacy Policy
  • Cookie Policy
  • Data Policy
  • Copyright Policy
  • Updated :  Subscriber Agreement
    & Terms of Use
  • Your Ad Choices
    •

  • Ads

  • Advertise
  • Place a Classified Ad
  • Sell Your Home
  • Sell Your Business
  • Commercial Real Estate Ads
  • Recruitment & Career Ads
  • Franchising
  • Advertise Locally
    •

  • Tools & Features

  • Apps
  • Emails & Alerts
  • Graphics & Photos
  • Columns
  • Topics
  • Guides
  • Portfolio
  • Old Portfolio
    •

  • More

  • Register for Free
  • Reprints
  • Content Partnerships
  • Conferences
  • Mobile Site
  • News Archive
    •
  • Jobs at WSJ
  • Copyright ©2014 Dow Jones & Company, Inc. All Rights Reserved.
    •